Irina Kranz - 01 Oct 2021 Form 4 Insider Report for HARVEST HEALTH & RECREATION INC.

Role
Corporate Controller
Signature
/s/ Allison McBride, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
01 Oct 2021
Net transactions value
$0
Form type
4
Filing time
05 Oct 2021, 19:45:34 UTC
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HRVSF Stock Options Disposed to Issuer -50,000 -100% 0 01 Oct 2021 Subordinate Voting Shares 50,000 $4.07 Direct F1, F2
transaction HRVSF Stock Options Disposed to Issuer -50,000 -100% 0 01 Oct 2021 Subordinate Voting Shares 50,000 $1.48 Direct F1, F3
transaction HRVSF Stock Options Disposed to Issuer -50,000 -100% 0 01 Oct 2021 Subordinate Voting Shares 50,000 $2.75 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Exercise price is denominated and reported in Canadian dollars.
F2 The stock options were granted on January 9, 2020 and vest in four equal annual installments beginning on January 9, 2021. Adjusted pursuant to the Arrangement Agreement, dated as of May 10, 2021 (the "Arrangement Agreement"), between Harvest Health and Recreation Inc. and Trulieve Cannabis Corp. ("Trulieve"), resulting in an option to receive 5,850 subordinate voting shares of Trulieve with an exercise price of CAD$34.79 per share.
F3 The stock options were granted on July 14, 2021 and vest in four equal annual installments beginning on July 14, 2021. Adjusted pursuant to the Arrangement Agreement resulting in an option to receive 5,850 subordinate voting shares of Trulieve with an exercise price of CAD$12.65 per share.
F4 The stock options were granted on December 31, 2020 and vest in four equal annual installments beginning on December 31, 2021. Adjusted pursuant to the Arrangement Agreement resulting in an option to receive 5,850 subordinate voting shares of Trulieve with an exercise price of CAD$23.51 per share.